4Toorenvliet B,Vellekoop A,Bakker R,et al.Clinical Differentiation be-tween Acute Appendicitis and Acute Mesenteric Lymphadenitis in Chil-dren[J].Eur J Pediatr Surg,2011,21(2):120-123.
5Frisch M,Pedersen BV,Andersson RE.Appendicitis,mesenteric lym-phadenitis,and subsequent risk of ulcerative colitis:cohort studies in Sweden and Denmark[J].BMJ,2009,9(338):b716.
2Horvat M, Krebs B, Potrc S,et al. Preoperative synbiotic bowel conditioning for elective colorectal surgery [J]. Wien Klin Wochenschr, 2010,122 ( Suppl 2): 26-30.
3Nespoli L,Uggeri F,Romano F,et al. Modulation of sys- temic and intestinal immune response by interleukin-2 therapy in gastrointestinal surgical oncology. Personal ex- perience in the context of current knowledge and future perspectives[J]. Anticancer Res,2012,32(3):989-996.
4Brzozowski T, Konturek PC, Mierzwa M, et al. Effect of probiotics and triple eradication therapy on the cyclooxy- genase(COX)-2 expression,apoptosis,and functional gas- tric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils[J]. Helicobacter, 2006,11 ( 1 ) :10-20.
5Marotta F, Naito Y, Minelli E, et al. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experi- mental study[J]. Hepatogastroenterology, 2003,50 (54) : 1914-1918.
6Mitsuyama K, Tomiyasu N, Takaki K, et al. Interleukin- 10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase [J]. Mediators Inflamm, 2006,6 : 26875.
